Logan G Spector1, Morton B Brown2, Ethan Wantman3, Gerard S Letterie4, James P Toner5, Kevin Doody6, Elizabeth Ginsburg7, Melanie Williams8, Lori Koch9, Maria J Schymura10, Barbara Luke11. 1. Division of Epidemiology/Clinical Research, Department of Pediatrics, University of Minnesota, Minneapolis. 2. Department of Biostatistics, School of Public Health, University of Michigan, Ann Arbor. 3. Redshift Technologies Inc, New York, New York. 4. Seattle Reproductive Medicine, Seattle, Washington. 5. Division of Reproductive Endocrinology and Infertility, Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, Georgia. 6. Center for Assisted Reproduction, Bedford, Texas. 7. Department of Obstetrics and Gynecology, Brigham and Women's Hospital, Boston, Massachusetts. 8. Cancer Epidemiology and Surveillance Branch, Texas Department of State Health Services, Austin. 9. Illinois State Cancer Registry, Department of Human Services, Springfield. 10. Bureau of Cancer Epidemiology and New York State Cancer Registry, New York State Department of Health, Albany. 11. Department of Obstetrics, Gynecology, and Reproductive Biology, College of Human Medicine, Michigan State University, East Lansing.
Abstract
Importance: In vitro fertilization (IVF) is associated with birth defects and imprinting disorders. Because these conditions are associated with an increased risk of childhood cancer, many of which originate in utero, descriptions of cancers among children conceived via IVF are imperative. Objective: To compare the incidence of childhood cancers among children conceived in vitro with those conceived naturally. Design, Setting, and Participants: A retrospective, population-based cohort study linking cycles reported to the Society for Assisted Reproductive Technology Clinical Outcomes Reporting System from January 1, 2004, to December 31, 2012, that resulted in live births from September 1, 2004, to December 31, 2013, to the birth and cancer registries of 14 states, comprising 66% of United States births and 75% of IVF-conceived births, with follow-up from September 1, 2004, to December 31, 2014. The study included 275 686 children conceived via IVF and a cohort of 2 266 847 children, in which 10 births were randomly selected for each IVF birth. Statistical analysis was performed from April 1, 2017, to October 1, 2018. Exposure: In vitro fertilization. Main Outcomes and Measures: Cancer diagnosed in the first decade of life. Results: A total of 321 cancers were detected among the children conceived via IVF (49.1% girls and 50.9% boys; mean [SD] age, 4.6 [2.5] years for singleton births and 5.9 [2.4] years for multiple births), and a total of 2042 cancers were detected among the children not conceived via IVF (49.2% girls and 50.8% boys; mean [SD] age, 6.1 [2.6] years for singleton births and 4.7 [2.6] years for multiple births). The overall cancer rate (per 1 000 000 person-years) was 251.9 for the IVF group and 192.7 for the non-IVF group (hazard ratio, 1.17; 95% CI, 1.00-1.36). The rate of hepatic tumors was higher among the IVF group than the non-IVF group (hepatic tumor rate: 18.1 vs 5.7; hazard ratio, 2.46; 95% CI, 1.29-4.70); the rates of other cancers did not differ between the 2 groups. There were no associations with specific IVF treatment modalities or indication for IVF. Conclusions and Relevance: This study found a small association of IVF with overall cancers of early childhood, but it did observe an increased rate of embryonal cancers, particularly hepatic tumors, that could not be attributed to IVF rather than to underlying infertility. Continued follow-up for cancer occurrence among children conceived via IVF is warranted.
Importance: In vitro fertilization (IVF) is associated with birth defects and imprinting disorders. Because these conditions are associated with an increased risk of childhood cancer, many of which originate in utero, descriptions of cancers among children conceived via IVF are imperative. Objective: To compare the incidence of childhood cancers among children conceived in vitro with those conceived naturally. Design, Setting, and Participants: A retrospective, population-based cohort study linking cycles reported to the Society for Assisted Reproductive Technology Clinical Outcomes Reporting System from January 1, 2004, to December 31, 2012, that resulted in live births from September 1, 2004, to December 31, 2013, to the birth and cancer registries of 14 states, comprising 66% of United States births and 75% of IVF-conceived births, with follow-up from September 1, 2004, to December 31, 2014. The study included 275 686 children conceived via IVF and a cohort of 2 266 847 children, in which 10 births were randomly selected for each IVF birth. Statistical analysis was performed from April 1, 2017, to October 1, 2018. Exposure: In vitro fertilization. Main Outcomes and Measures: Cancer diagnosed in the first decade of life. Results: A total of 321 cancers were detected among the children conceived via IVF (49.1% girls and 50.9% boys; mean [SD] age, 4.6 [2.5] years for singleton births and 5.9 [2.4] years for multiple births), and a total of 2042 cancers were detected among the children not conceived via IVF (49.2% girls and 50.8% boys; mean [SD] age, 6.1 [2.6] years for singleton births and 4.7 [2.6] years for multiple births). The overall cancer rate (per 1 000 000 person-years) was 251.9 for the IVF group and 192.7 for the non-IVF group (hazard ratio, 1.17; 95% CI, 1.00-1.36). The rate of hepatic tumors was higher among the IVF group than the non-IVF group (hepatic tumor rate: 18.1 vs 5.7; hazard ratio, 2.46; 95% CI, 1.29-4.70); the rates of other cancers did not differ between the 2 groups. There were no associations with specific IVF treatment modalities or indication for IVF. Conclusions and Relevance: This study found a small association of IVF with overall cancers of early childhood, but it did observe an increased rate of embryonal cancers, particularly hepatic tumors, that could not be attributed to IVF rather than to underlying infertility. Continued follow-up for cancer occurrence among children conceived via IVF is warranted.
Authors: Michael L Eisenberg; Barbara Luke; Katherine Cameron; Gary M Shaw; Allan A Pacey; Alastair G Sutcliffe; Carrie Williams; Julian Gardiner; Richard A Anderson; Valerie L Baker Journal: J Assist Reprod Genet Date: 2020-09-30 Impact factor: 3.412
Authors: J Alejandro Rauh-Hain; Jose Zubizarreta; Roni Nitecki; Alexander Melamed; Shuangshuang Fu; Kirsten Jorgensen; Paula C Brady; Valerie L Baker; Mariana Chavez-MacGregor; Sharon H Giordano; Nancy L Keating Journal: Cancer Date: 2022-06-29 Impact factor: 6.921
Authors: Barbara Luke; Morton B Brown; Ethan Wantman; Nina E Forestieri; Marilyn L Browne; Sarah C Fisher; Mahsa M Yazdy; Mary K Ethen; Mark A Canfield; Hazel B Nichols; Sergio Oehninger; Kevin J Doody; Alastair G Sutcliffe; Carrie Williams; Michael L Eisenberg; Valerie L Baker; Caitlin R Sacha; Philip J Lupo Journal: J Assist Reprod Genet Date: 2021-02-05 Impact factor: 3.412
Authors: Barbara Luke; Morton B Brown; Ethan Wantman; Nina E Forestieri; Marilyn L Browne; Sarah C Fisher; Mahsa M Yazdy; Mary K Ethen; Mark A Canfield; Stephanie Watkins; Hazel B Nichols; Leslie V Farland; Sergio Oehninger; Kevin J Doody; Michael L Eisenberg; Valerie L Baker Journal: Hum Reprod Date: 2021-01-01 Impact factor: 6.918
Authors: Jeremy M Schraw; Tania A Desrosiers; Wendy N Nembhard; Peter H Langlois; Robert E Meyer; Mark A Canfield; Sonja A Rasmussen; Tiffany M Chambers; Logan G Spector; Sharon E Plon; Philip J Lupo Journal: Cancer Date: 2020-05-29 Impact factor: 6.860
Authors: Gulam Bahadur; Roy Homburg; Judith E Bosmans; Judith A F Huirne; Peter Hinstridge; Kanna Jayaprakasan; Paul Racich; Rakib Alam; Ioannis Karapanos; Afeeza Illahibuccus; Ansam Al-Habib; Eric Jauniaux Journal: BMJ Open Date: 2020-03-16 Impact factor: 2.692